Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74(3):229–63.

Article  Google Scholar 

Hon CC, Yan H, Bu P. Non-coding RNA in cancer. Essays Biochem. 2021;65(4):625–39.

Article  Google Scholar 

Bridges MC, Daulagala AC, Kourtidis A. LNCcation: lncRNA localization and function. J Cell Biol. 2021. https://doi.org/10.1083/jcb.202009045.

Article  PubMed  PubMed Central  Google Scholar 

Xing C, Sun S-g, Yue Z-Q, Bai F. Role of lncRNA LUCAT1 in cancer. Biomed Pharmacother. 2021. https://doi.org/10.1016/j.biopha.2020.111158.

Article  PubMed  Google Scholar 

Smolarz B, Zadrożna-Nowak A, Romanowicz H. The Role of lncRNA in the Development of Tumors, including Breast Cancer. Int J Mol Sci. 2021;22(16):8427.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rajagopal T, Talluri S, Akshaya RL, Dunna NR. HOTAIR LncRNA: A novel oncogenic propellant in human cancer. Clin Chim Acta. 2020;503:1–18.

Article  CAS  PubMed  Google Scholar 

Chen Y, Li Z, Chen X, Zhang S. Long non-coding RNAs: From disease code to drug role. Acta Pharmaceutica Sinica B. 2021;11(2):340–54.

Article  CAS  PubMed  Google Scholar 

Herman AB, Tsitsipatis D, Gorospe M. Integrated lncRNA function upon genomic and epigenomic regulation. Mol Cell. 2022;82(12):2252–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang L, Cho KB, Li Y, Tao G, Xie Z, Guo B. Long Noncoding RNA (lncRNA)-Mediated Competing Endogenous RNA Networks Provide Novel Potential Biomarkers and Therapeutic Targets for Colorectal Cancer. Int J Mol Sci. 2019;20(22):5758.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo K, Qian K, Shi Y, Sun T, Wang Z. LncRNA-MIAT promotes thyroid cancer progression and function as ceRNA to target EZH2 by sponging miR-150–5p. Cell Death Dis. 2021;12(12):1097.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ge Q, Jia D, Cen D, Qi Y, Shi C, Li J, et al. Micropeptide ASAP encoded by LINC00467 promotes colorectal cancer progression by directly modulating ATP synthase activity. J Clin Invest. 2021;131(22):e152911.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tan YT, Lin JF, Li T, Li JJ, Xu RH, Ju HQ. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun. 2020;41(2):109–20.

Article  Google Scholar 

Wang Y, Liu F, Chen L, Fang C, Li S, Yuan S, et al. Neutrophil Extracellular Traps (NETs) Promote Non-Small Cell Lung Cancer Metastasis by Suppressing lncRNA MIR503HG to Activate the NF-κB/NLRP3 Inflammasome Pathway. Front Immunol. 2022;13:867516.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Loewen G, Jayawickramarajah J, Zhuo Y, Shan B. Functions of lncRNA HOTAIR in lung cancer. J Hematol Oncol. 2014;7:90.

Article  PubMed  PubMed Central  Google Scholar 

Wang Q, Li X, Ren S, Su C, Li C, Li W, et al. HOTAIR induces EGFR-TKIs resistance in non-small cell lung cancer through epithelial-mesenchymal transition. Lung Cancer. 2020;147:99–105.

Article  PubMed  Google Scholar 

Kong X, Duan Y, Sang Y, Li Y, Zhang H, Liang Y, et al. LncRNA–CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215. J Cell Physiol. 2018;234(6):9105–17.

Article  PubMed  Google Scholar 

Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6(1):74. https://doi.org/10.1038/s41392-020-00450-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun T, Wu R, Ming L. The role of m6A RNA methylation in cancer. Biomed Pharmacother. 2019;112:108613.

Article  CAS  PubMed  Google Scholar 

Ma S, Chen C, Ji X, Liu J, Zhou Q, Wang G, et al. The interplay between m6A RNA methylation and noncoding RNA in cancer. J Hematol Oncol. 2019;12(1):121.

Article  PubMed  PubMed Central  Google Scholar 

He L, Li H, Wu A, Peng Y, Shu G, Yin G. Functions of N6-methyladenosine and its role in cancer. Mol Cancer. 2019;18(1):176.

Article  PubMed  PubMed Central  Google Scholar 

Wang T, Kong S, Tao M, Ju S. The potential role of RNA N6-methyladenosine in Cancer progression. Mol Cancer. 2020;19(1):88.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li J, Wang X, Wang H. RNA modifications in long non-coding RNAs and their implications in cancer biology. Bioorg Med Chem. 2024;113: 117922.

Article  CAS  PubMed  Google Scholar 

Zhuang H, Yu B, Tao D, Xu X, Xu Y, Wang J, et al. The role of m6A methylation in therapy resistance in cancer. Mol Cancer. 2023;22(1):91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

An Y, Duan H. The role of m6A RNA methylation in cancer metabolism. Mol Cancer. 2022;21(1):14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deng L-J, Deng W-Q, Fan S-R, Chen M-F, Qi M, Lyu W-Y, et al. m6A modification: recent advances, anticancer targeted drug discovery and beyond. Mol Cancer. 2022;21(1):52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yi P, Zou D, Yu J, Yu J, Wang F, Rao S, et al. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation. Nucleic Acids Res. 2020;48(7):3816–31.

Article  PubMed  PubMed Central  Google Scholar 

Ji F-H, Fu X-H, Li G-Q, He Q, Qiu X-G. FTO Prevents Thyroid Cancer Progression by SLC7A11 m6A Methylation in a Ferroptosis-Dependent Manner. Front Endocrinol. 2022;13:857765.

Article  Google Scholar 

Chen X, Xu M, Xu X, Zeng K, Liu X, Pan B, et al. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer. Mol Cancer. 2020;19(1):106.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jin Y, Fan Z. New insights into the interaction between m6A modification and lncRNA in cancer drug resistance. Cell Proliferation. 2023;57(4).

Núñez-Martínez HN, Recillas-Targa F. Emerging Functions of lncRNA Loci beyond the Transcript Itself. Int J Mol Sci. 2022;23(11):6258.

Article  PubMed  PubMed Central  Google Scholar 

Zhang J, Wei J, Sun R, Sheng H, Yin K, Pan Y, et al. A lncRNA from the FTO locus acts as a suppressor of the m(6)A writer complex and p53 tumor suppression signaling. Mol Cell. 2023;83(15):2692-708.e7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou L, Jiang J, Huang Z, Jin P, Peng L, Luo M, et al. Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m6A-mediated degradation of STEAP3 mRNA. Mol Cancer. 2022;21(1):168.

Article  CAS